The company confirmed that it has set a date of October 13th, 2010 for the official rollout of its SYGNUS Implantable Contact System, which combines electrical contacts and isolation seals in a standardized, platform-ready “stack” configuration to provide a turnkey connecting solution for implantable devices used in cardiac rhythm management, neuromodulation, and neuro sensing therapies.
According to Bal Seal, the new SYGNUS system pairs the company’s Bal Conn electrical contact technology with pre-tested silicone seals, resulting in an “all-inclusive package” engineered to help large and small device OEMs improve speed to market and eliminate the need for procurement and testing of individual components.
Bal Seal said the number of contacts and seals in the SYGNUS system will be configurable to meet unique application and industry requirements, such as the IS4 standard for cardiac health management devices. The Canted-coil spring contact design will offer multi-point conductivity and low insertion force, and will compensate for any surface irregularity, no matter how small. The system’s precision-engineered silicone seals will provide superior dielectric isolation, and the combined stack will offer excellent resistance to long-term material adhesion and potential fatigue caused by multiple lead insertion cycles. Contacts in the stack will be force and resistance tested, and sealing components will be packaged to critical clean standards.